Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners.
Chiba T, Suzuki E, Yuki K, Zen Y, Oshima M, Miyagi S, Saraya A, Koide S, Motoyama T, Ogasawara S, Ooka Y, Tawada A, Nakatsura T, Hayashi T, Yamashita T, Kaneko S, Miyazaki M, Iwama A, Yokosuka O. Chiba T, et al. Among authors: nakatsura t. PLoS One. 2014 Jan 13;9(1):e84807. doi: 10.1371/journal.pone.0084807. eCollection 2014. PLoS One. 2014. PMID: 24454751 Free PMC article.
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma.
Shirakawa H, Suzuki H, Shimomura M, Kojima M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T. Shirakawa H, et al. Among authors: nakatsura t. Cancer Sci. 2009 Aug;100(8):1403-7. doi: 10.1111/j.1349-7006.2009.01206.x. Epub 2009 May 4. Cancer Sci. 2009. PMID: 19496787 Free PMC article.
Peptide vaccines for hepatocellular carcinoma.
Nobuoka D, Yoshikawa T, Sawada Y, Fujiwara T, Nakatsura T. Nobuoka D, et al. Among authors: nakatsura t. Hum Vaccin Immunother. 2013 Jan;9(1):210-2. doi: 10.4161/hv.22473. Hum Vaccin Immunother. 2013. PMID: 23442593 Free PMC article.
Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.
Ofuji K, Saito K, Suzuki S, Shimomura M, Shirakawa H, Nobuoka D, Sawada Y, Yoshimura M, Tsuchiya N, Takahashi M, Yoshikawa T, Tada Y, Konishi M, Takahashi S, Gotohda N, Nakamoto Y, Nakatsura T. Ofuji K, et al. Among authors: nakatsura t. Oncotarget. 2017 Jun 6;8(23):37835-37844. doi: 10.18632/oncotarget.14271. Oncotarget. 2017. PMID: 28035063 Free PMC article.
143 results